{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:35:21Z","timestamp":1793957721699,"version":"4.8.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22fk0108628"],"award-info":[{"award-number":["JP22fk0108628"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jiac.2025.102637","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:05:36Z","timestamp":1738271136000},"page":"102637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A transient reduction of the varicella-zoster virus-specific immunoglobulin G level after vaccination against severe acute respiratory syndrome coronavirus 2 with an mRNA vaccine in nursing home residents, but not staff"],"prefix":"10.1016","volume":"31","author":[{"given":"Masae","family":"Itamochi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Yazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Saga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6309-277X","authenticated-orcid":false,"given":"Hideki","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102637_bib1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the bnt162b2 mrna covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102637_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the bnt162b2 mrna covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102637_bib3","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (vzv)-specific cell-mediated immunity with increasing age and boosting with a high-dose vzv vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2025.102637_bib4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/jdv.18184","article-title":"Real-world evidence from over one million covid-19 vaccinations is consistent with reactivation of the varicella-zoster virus","volume":"36","author":"Hertel","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jiac.2025.102637_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14760584.2023.2232451","article-title":"Risk of herpes zoster following mrna covid-19 vaccine administration","volume":"22","author":"Florea","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jiac.2025.102637_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.42240","article-title":"Assessment of herpes zoster risk among recipients of covid-19 vaccine","volume":"5","author":"Akpandak","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2025.102637_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaad.2021.11.025","article-title":"Risk of herpes zoster reactivation after messenger rna covid-19 vaccination: a cohort study","volume":"87","author":"Birabaharan","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jiac.2025.102637_bib8","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2023.02.068","article-title":"Neutralization of omicron subvariants ba.1 and ba.5 by a booster dose of covid-19 mrna vaccine in a Japanese nursing home cohort","volume":"41","author":"Itamochi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2025.102637_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105100","article-title":"Specific and off-target immune responses following covid-19 vaccination with chadox1-s and bnt162b2 vaccines-an exploratory sub-study of the brace trial","volume":"103","author":"Messina","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jiac.2025.102637_bib10","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1002\/jmv.27895","article-title":"Unremarkable antibody responses against various infectious agents after inoculation with the bnt162b2 covid-19 vaccine","volume":"94","author":"Kozawa","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jiac.2025.102637_bib11","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/s41467-023-37407-x","article-title":"Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2025.102637_bib12","article-title":"Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of sars-cov-2 mrna vaccine","volume":"3","author":"Takano","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jiac.2025.102637_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the bnt162b2 mrna vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jiac.2025.102637_bib14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2147\/JPR.S405157","article-title":"T lymphocyte subsets profile and toll-like receptors responses in patients with herpes zoster","volume":"16","author":"Chen","year":"2023","journal-title":"J Pain Res"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:49:23Z","timestamp":1762368563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1341321X25000339"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102637","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A transient reduction of the varicella-zoster virus-specific immunoglobulin G level after vaccination against severe acute respiratory syndrome coronavirus 2 with an mRNA vaccine in nursing home residents, but not staff","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102637"}}